John L’Ecuyer

As part of Putnam’s Portfolio, Licensing & Development practice, John helps clients build clinical development and go-to-market strategies.

Across therapy areas, he has helped clients drive strategic prioritization decisions about where to position their early-stage assets in the future treatment paradigm, how to determine the target profile and clinical development path required to win and differentiate, and how to size the opportunity and weigh trade-offs.

He joined SmartAnalyst (now part of Putnam) in 2003 and has partnered with biopharma clients in North America, Europe, and Asia-Pacific to provide data-driven strategies and insights that inform important clinical development and investment decisions. Prior to SmartAnalyst, he worked in healthcare communications, where he supported media relations for healthcare providers and biotech companies. He graduated summa cum laude from Columbia University.